Ortin Global P/B Ratio
Ortin Global (ORTINGLOBE) P/B ratio is 9.14 (High), book value per share ₹2.50 vs Healthcare average P/B of -0.94 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Ortin Global share price screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ORTINGLOBE P/B Ratio — Valuation Insights & Book Value Analysis
Ortin Global price-to-book ratio interpretation, valuation status and historical context — current P/B 9.14 (High). Compare with ORTINGLOBE fair value to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 9.14, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 173.5% above historical average
- Trading at premium to sector average PB of -0.94
Ortin Global P/B Ratio Historical Trend
ORTINGLOBE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Ortin Global yearly highs lows for the annual high/low range and current price position.
ORTINGLOBE Historical P/B Ratio — Book Value Per Share & Year-End Price
Ortin Global annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 6.16 | ₹2.5 | ₹15.41 | ₹2 | High |
| 2024 | 4.77 | ₹3.75 | ₹17.90 | ₹3 | High |
| 2023 | 1.67 | ₹13.75 | ₹23.02 | ₹11 | Moderate |
| 2022 | 1.72 | ₹13.75 | ₹23.70 | ₹11 | Moderate |
| 2021 | 2.39 | ₹13.75 | ₹32.90 | ₹11 | Moderate |
ORTINGLOBE vs Healthcare Peers — P/B Ratio Comparison
Ortin Global P/B 9.14 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |